Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Idaho for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Idaho only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Idaho (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Acme Markets Inc (NPI 1558452185)

Field	Value
Entity Type	Organization
Organization	Acme Markets Inc
Address	250 E Parkcenter Blvd
City	Boise
State	ID
ZIP	83706
Taxonomy	Community/Retail Pharmacy
NPI Enumerated	September 27, 2006

Payer Source	Total Paid
Medicare	$9.5M
Medicaid	$0

Key Findings

ACME MARKETS INC operates as a community/retail pharmacy with a Medicare code mix dominated by vaccine administration and COVID testing. The top revenue-producing codes are vaccines and test provisions: 91320 (14.9K claims, $128 avg paid/claim, $1.9M revenue (20.0% of this provider's total Medicare revenue)), 90662 (26.3K claims, $72 avg paid/claim, $1.9M revenue (19.9% of this provider's total Medicare revenue)), and K1034 (118.3K claims, $12 avg paid/claim, $1.4M revenue (14.9% of this provider's total Medicare revenue)), all of which point to a high-throughput immunization and point-of-care testing operation rather than a clinician-provided procedural practice.

Revenue is highly concentrated in a few services: the top 3 Medicare codes by revenue account for 54.8% of this provider's total Medicare revenue, against a reported total Medicare revenue of $9.5M. This concentration means changes in vaccine demand, program reimbursement, or test supply could materially affect overall Medicare income for the entity.

ACME MARKETS is effectively single-payer in the claims data provided: total Medicare revenue is $9.5M while there is no Medicaid billing on file ("none below"). Analysts should treat Medicaid exposure as nil in state-level comparisons and model payer mix accordingly.

The provider is a national outlier on multiple vaccine administration codes, indicating dominant volume versus peers. For example, 91320 ranks #7 of 27083 providers nationally (100th percentile; extreme outlier) and 90662 ranks #8 of 70752 providers nationally (100th percentile; extreme outlier), and additional administration codes such as 90480 and G0008 also show top-10 national ranks and 100th-percentile status, consistent with a major national presence for retail immunization services.

K1034 (nonprescription self-administered COVID test) shows very large absolute volume—118.3K claims, $12 avg paid/claim, $1.4M revenue (14.9% of this provider's total Medicare revenue)—but ranks #159 of 30143 providers nationally (99th percentile; typical, unremarkable volume). In plain terms, the provider processed many tests in absolute terms but sits within the expected national distribution for this test code rather than as a statistical extreme.

ACME also records strong volume in higher-priced vaccine products, signaling a broad immunization portfolio beyond routine flu shots. For instance, 90677 (pneumococcal 20-valent) shows 2.1K claims, $282 avg paid/claim, $578.7K revenue (6.1% of this provider's total Medicare revenue) and ranks #8 of 52451 providers nationally (100th percentile; extreme outlier), indicating disproportionate market share in select higher-cost adult vaccines.

Seasonal influenza services are a central revenue stream: 90662 (26.3K claims, $72 avg paid/claim, $1.9M revenue (19.9%)) and G0008 (28.9K claims, $32 avg paid/claim, $924.4K revenue (9.7%)) together reflect sustained high-volume flu vaccine administration. These figures are consistent with a retail pharmacy model that captures routine preventive care at scale during seasonal campaigns.

The provider has a long-tenured NPI (enumerated 2006-09-27 (~20 years ago)), which, combined with repeated 100th-percentile ranks on multiple administration codes, suggests an established market presence and operational maturity in delivering retail vaccination and testing services rather than a newly entered or sporadic billing entity. This tenure should be considered when assessing competitive positioning and contracting leverage with payers.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

13 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
91320	This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL.	14,900	$130	$1.9M
90662	This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection…	26,310	$70	$1.9M
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	118,280	$10	$1.4M
91322	This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL.	9,480	$140	$1.4M
90480	The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19.	24,390	$40	$1M
G0008	Administration of influenza virus vaccine	28,890	$30	$924.4K
90677	This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the…	2,050	$280	$578.7K
0124A	N/A	3,570	$40	$153.3K
90682	This code represents a quadrivalent flu vaccine given by injection into the muscle. The vaccine is made using recombinant DNA technology and contains only a protein from the virus. It does not…	1,190	$70	$85.3K
G0009	Administration of pneumococcal vaccine	2,110	$30	$69.6K

Showing 1–10 of 13

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Idaho Distribution

Acme Markets Inc — 8 of 13 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Idaho

Full comparison — all codes billed, vs. state median

13 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
91322	7	140	70	$140	$244.4K
K1034	6	120	310	$10	$233.1K
91320	5	140	60	$130	$231.6K
90662	6	220	60	$70	$161.5K
90480	6	210	80	$40	$96K
90677	6	160	20	$280	$81.2K
90682	6	20	100	$70	$77.3K
G0008	6	410	50	$30	$42.3K
0134A	8	70	20	$40	$40.4K
0124A	6	80	30	$40	$39.8K

Showing 1–10 of 13

Nearby Providers

Other providers in the same ZIP code as Acme Markets Inc, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Safeway Inc	ID	Community/Retail Pharmacy	$76.1M	$330
Albertsons LLC	ID	Community/Retail Pharmacy	$29M	$0
American Drug Stores LLC	ID	Community/Retail Pharmacy	$27.3M	$0
Vons Companies Inc	ID	Community/Retail Pharmacy	$12.7M	$0
Nai Saturn Eastern LLC	ID	Community/Retail Pharmacy	$12.6M	$0
Smiles 4 Kids	ID	Dentist	$0	$9.6M
Randalls Food & Drugs LP	ID	Community/Retail Pharmacy	$6.7M	$0
Shaws Supermarkets Inc	ID	Community/Retail Pharmacy	$5.5M	$0
Saint Alphonsus Regional Medical Center Inc	ID	General Acute Care Hospital	$0	$5.1M
Tdandc LLC	ID	Home Health Agency	$0	$4.9M

Acme Markets Inc — Billing Profile & Reimbursement Data

Sign up for Acme Markets Inc — Billing Profile & Reimbursement Data policy alerts

Acme Markets Inc — Billing Profile & Reimbursement Data

Sign up for Acme Markets Inc — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References